Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)
9.19
+0.19 (2.11%)
At close: Aug 3, 2026
SHE:301126 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 5,229 | 5,144 | 5,233 | 3,904 | 3,292 | 2,592 |
Revenue Growth | -0.46% | -1.70% | 34.07% | 18.56% | 27.01% | 10.79% |
Gross Profit Gross Profit Growth | 945.83 | 932.12 | 1,036 | 568.05 | 391.68 | 300.35 |
Operating Income Operating Income Growth | 81.07 | 83.14 | 196.75 | 122.61 | 108.23 | 128.3 |
Net Income Net Income Growth | -239.64 | -242.46 | 26.57 | 34.3 | 51.08 | 68.26 |
Earnings Per Share EPS Growth | -1.11 | -1.18 | 0.13 | 0.17 | 0.25 | 0.44 |
EPS Growth | - | - | -23.53% | -32.00% | -43.18% | 4.76% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Pharmaceutical Distribution Pharmaceutical Distribution Growth | 1,960 | 2,214 | 2,301 | 2,276 | 1,880 |
Pharmaceutical Retail Pharmaceutical Retail Growth | 2,942 | 2,692 | 1,505 | 993.4 | 691.07 |
Hospital income Hospital income Growth | 10.66 | 14.41 | 12.77 | 9.45 | 14.77 |
Drug production revenue Drug production revenue Growth | 215.15 | 299.84 | 75.85 | - | - |
Other Income Other Income Growth | 16.86 | 13.33 | 8.43 | - | - |
Total Total Growth | 5,144 | 5,233 | 3,904 | 3,292 | 2,592 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 529.87 | 596.55 | 619.85 | 649.4 | 643 | 748.07 |
Total Debt Total Debt Growth | 3,665 | 3,672 | 3,286 | 2,574 | 1,610 | 753.41 |
Net Cash (Debt) Net Cash Growth | -3,135 | -3,075 | -2,666 | -1,925 | -967.4 | -5.34 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -14.52 | -14.97 | -13.04 | -9.54 | -4.73 | -0.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -15.71 | -149.12 | 24.04 | 27.13 | -493.96 | -161.81 |
Capital Expenditures CapEx Growth | -93.46 | -104.63 | -187.14 | -226.7 | -208.73 | -33.29 |
Free Cash Flow Free Cash Flow Growth | -109.17 | -253.75 | -163.1 | -199.57 | -702.69 | -195.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 18.09% | 18.12% | 19.80% | 14.55% | 11.90% | 11.59% |
Operating Margin | 1.55% | 1.62% | 3.76% | 3.14% | 3.29% | 4.95% |
Pretax Margin | -4.20% | -4.28% | 1.45% | 1.24% | 2.31% | 3.70% |
Profit Margin | -4.58% | -4.71% | 0.51% | 0.88% | 1.55% | 2.63% |
FCF Margin | -2.09% | -4.93% | -3.12% | -5.11% | -21.34% | -7.53% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.104 | 0.022 | 0.082 | 0.040 | 0.029 | 0.034 |
Dividend Per Share Growth | 0% | -73.11% | 104.50% | 37.93% | -14.71% | - |
Dividend Yield | 1.13% | 0.18% | 0.79% | 0.31% | 0.20% | 0.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 80.69 | 78.45 | 60.20 | 68.65 |
PS Ratio | 0.36 | 0.49 | 0.41 | 0.69 | 0.93 | 1.81 |